OPTH
Optimi Health Corp. Common SharesstockNASDAQ
Market OpenNov 19, 2026 3:24:59 PM EST
1.78USD-7.050%(-0.13)22,247
OPTH News
Optimi Health completes MDMA batch for Canadian phase 3 trial ·
Investing.com
Optimi Health to Present at the ThinkEquity Conference ·
GlobeNewswire Inc.+1 source
Optimi Health Appoints Melanie Pump to Board of Directors ·
GlobeNewswire Inc.+2 sources
Optimi Health produces psilocybin capsules for Phase II MDD study ·
Clinical Trials Arena
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply ·
GlobeNewswire Inc.+1 source
Optimi Health appoints Michael Blough as clinical officer ·
Investing.com
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer ·
GlobeNewswire Inc.+1 source